PRICE T ROWE ASSOCIATES INC /MD/
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 80255
BALTIMORE, MD
Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$398,367
+$21,390 QoQ
Shares Held
140,766
+21.4% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. MRVI ranks #192 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,206,618 | $305,117,340 |
All Filings in MRVI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $398,367 | 140,766 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $376,977 | 115,993 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $332,899 | 115,993 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $214,473 | 88,993 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $183,038 | 82,823 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $386,012 | 70,828 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $522,549 | 62,882 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $442,939 | 61,863 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $638,068 | 73,595 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $458,631 | 70,020 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $861,070 | 86,107 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,128,820 | 975,770 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,656,107 | 974,740 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,888,212 | 970,525 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $33,172,788 | 1,299,365 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $46,809,083 | 1,647,627 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $72,266,713 | 2,048,957 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $81,568,238 | 1,946,736 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $75,020,399 | 1,528,533 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $35,578,246 | 852,582 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,928,315 | 334,689 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||